A CEO who fakes a stock purchase, delays a phase III trial due to a supposed lack of participants (extremely implausible with n=200), and regularly subtly offers the company for sale through self-promotion. What does that tell you?
Exactly! He knows his strategy will fail.
- Forums
- ASX - By Stock
- CUV
- REPORT JUST DROPPED - Check this out!
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
1.02%
!
$9.66

REPORT JUST DROPPED - Check this out!, page-11
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$9.66 |
Change
-0.100(1.02%) |
Mkt cap ! $486.1M |
Open | High | Low | Value | Volume |
$9.58 | $9.90 | $9.44 | $994.8K | 102.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 87 | $9.67 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.69 | 177 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 208 | 9.670 |
4 | 128 | 9.660 |
4 | 422 | 9.650 |
2 | 106 | 9.640 |
2 | 1948 | 9.630 |
Price($) | Vol. | No. |
---|---|---|
9.700 | 214 | 4 |
9.710 | 12080 | 5 |
9.720 | 244 | 6 |
9.730 | 354 | 4 |
9.740 | 89 | 3 |
Last trade - 15.09pm 18/06/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online